
Venkataraman Balasubramanian
Examiner (ID: 8143, Phone: (571)272-0662 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611 |
| Total Applications | 2999 |
| Issued Applications | 2024 |
| Pending Applications | 254 |
| Abandoned Applications | 724 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16681670
[patent_doc_number] => 10941136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Quinazoline derivative or its salt and pharmaceutical composition comprising the same
[patent_app_type] => utility
[patent_app_number] => 16/096712
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11296
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096712 | Quinazoline derivative or its salt and pharmaceutical composition comprising the same | Apr 25, 2017 | Issued |
Array
(
[id] => 14273499
[patent_doc_number] => 20190134034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Method of Treating Liver Cancer
[patent_app_type] => utility
[patent_app_number] => 16/094199
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094199 | Method of Treating Liver Cancer | Apr 20, 2017 | Abandoned |
Array
(
[id] => 11836231
[patent_doc_number] => 20170217949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => '4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES CONTAINING A SULFOXIMINE GROUP'
[patent_app_type] => utility
[patent_app_number] => 15/488155
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67082
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488155 | 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group | Apr 13, 2017 | Issued |
Array
(
[id] => 12158761
[patent_doc_number] => 20180030027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 15/485654
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126572
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485654 | INHIBITORS OF BRUTON'S TYROSINE KINASE | Apr 11, 2017 | Abandoned |
Array
(
[id] => 11836189
[patent_doc_number] => 20170217908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis'
[patent_app_type] => utility
[patent_app_number] => 15/484136
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21781
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/484136 | Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis | Apr 10, 2017 | Abandoned |
Array
(
[id] => 11987724
[patent_doc_number] => 20170291880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'PROCESS FOR THE PREPARATION OF TOLTRAZURIL AND AN INTERMEDIATE USEFUL FOR ITS PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/480565
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1141
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480565 | Process for the preparation of toltrazuril and an intermediate useful for its preparation | Apr 5, 2017 | Issued |
Array
(
[id] => 13106761
[patent_doc_number] => 10072013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Selective PI3K delta inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/480128
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14134
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480128 | Selective PI3K delta inhibitors | Apr 4, 2017 | Issued |
Array
(
[id] => 14566739
[patent_doc_number] => 20190210976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Compositions Of Crystallized Hydrophobic Compounds And Methods Of Making And Using Same
[patent_app_type] => utility
[patent_app_number] => 16/091330
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091330 | Compositions of crystallized hydrophobic compounds and methods of making and using same | Apr 3, 2017 | Issued |
Array
(
[id] => 11757237
[patent_doc_number] => 20170204104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT'
[patent_app_type] => utility
[patent_app_number] => 15/479145
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33893
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479145
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479145 | Compositions useful for treating disorders related to kit | Apr 3, 2017 | Issued |
Array
(
[id] => 14929791
[patent_doc_number] => 20190300533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => SUBSTITUTED PYRROLOPYRIMIDINE CDK INHIBITOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/087918
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087918
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087918 | Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof | Mar 26, 2017 | Issued |
Array
(
[id] => 11971137
[patent_doc_number] => 20170275290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/469975
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107402
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469975 | Pyrrolotriazine compounds as tam inhibitors | Mar 26, 2017 | Issued |
Array
(
[id] => 14171663
[patent_doc_number] => 10259826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
[patent_app_type] => utility
[patent_app_number] => 15/468467
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 86985
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468467
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468467 | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds | Mar 23, 2017 | Issued |
Array
(
[id] => 16028113
[patent_doc_number] => 10676463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Monoglycidyl isocyanurate compound and production method therefor
[patent_app_type] => utility
[patent_app_number] => 16/091770
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3581
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091770 | Monoglycidyl isocyanurate compound and production method therefor | Mar 23, 2017 | Issued |
Array
(
[id] => 11990434
[patent_doc_number] => 20170294589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/461914
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17310
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461914 | Compound and organic photoelectric device, image sensor and electronic device including the same | Mar 16, 2017 | Issued |
Array
(
[id] => 14317883
[patent_doc_number] => 20190148645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/088919
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088919 | Organic electroluminescent compound and organic electroluminescent device comprising the same | Mar 15, 2017 | Issued |
Array
(
[id] => 14422467
[patent_doc_number] => 10316023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Therapeutic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/449706
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20420
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449706 | Therapeutic compounds and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 14422467
[patent_doc_number] => 10316023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Therapeutic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/449706
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20420
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449706 | Therapeutic compounds and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 14422467
[patent_doc_number] => 10316023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Therapeutic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/449706
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20420
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449706 | Therapeutic compounds and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 14422467
[patent_doc_number] => 10316023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Therapeutic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/449706
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20420
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449706 | Therapeutic compounds and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 11668413
[patent_doc_number] => 20170157133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'NOVEL PYRIDAZONES AND TRIAZINONES FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/432706
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25531
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15432706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/432706 | Pyridazones and triazinones for treatment and prophylaxis of hepatitis B virus infection | Feb 13, 2017 | Issued |